Literature DB >> 8580033

Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

J S Cameron1.   

Abstract

Continuous ambulatory peritoneal dialysis (CAPD) has come to be extensively used for the treatment of end-stage renal failure in children, and especially infants, such that now more than half of children on dialysis worldwide receive treatment by this means. Peritonitis, however, is commoner in children than in adults receiving treatment, and is a major source of morbidity and treatment failure in children started on CAPD. Only recently has the immunology of the normal peritoneum been studied extensively, with the need to assess the impact of the installation of large volumes of fluid into the peritoneal sac during dialysis. The main phagocytic defences of the peritoneum depend upon a unique set of macrophages which are present free in the peritoneal fluid but also in the submesothelium and in perivascular collections together with B lymphocytes in the submesothelial area. Both the number of macrophages per unit volume and the concentration of opsonic proteins, such as IgG, complement and fibronectin, are reduced to between only 1% and 5% when dialysis fluid is continuously present in the peritoneal sac. In addition, the fluids used for CAPD are toxic to both macrophages and to mesothelial cells. Thus minor degrees of contamination frequently lead to peritonitis and in addition the majority of patients have catheters inserted in their peritoneum which become colonised with organisms capable of producing exopolysaccharide (slime), which promotes adhesion of the organism to the plastic and protects them against phagocytic attack and the penetration of antibiotics. Thus the peritoneum is in a state of continual inflammation, as well as being a markedly more vulnerable site than the normal peritoneum to the entry of organisms. Whether clinical peritonitis appears in this state of chronic contamination probably depends on perturbation in the balance between host defences and the organism. Whilst Staphylococcus epidermidis is the commonest cause of peritonitis, Staphylococcus aureus and Gram-negative organisms are much more serious and more frequently lead either to temporary catheter removal or discontinuation of dialysis altogether. This review describes the peritoneal defences in relation to the genesis of peritonitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580033     DOI: 10.1007/bf00860966

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  162 in total

Review 1.  Host defence in CAPD treatment: the effect of the dialysate on cell function.

Authors:  H van Bronswijk; H A Verbrugh; E C Heezius; R P Verkooyen; J van der Meulen; J Verhoef
Journal:  Contrib Nephrol       Date:  1990       Impact factor: 1.580

2.  Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.

Authors:  C S Goldstein; J S Bomalaski; R B Zurier; E G Neilson; S D Douglas
Journal:  Kidney Int       Date:  1984-11       Impact factor: 10.612

3.  Exit-site infection during continuous and cycling peritoneal dialysis in children.

Authors:  M Levy; J W Balfe; D Geary; S Fryer-Keene; R Bannatyne
Journal:  Perit Dial Int       Date:  1990       Impact factor: 1.756

4.  Toxicity of osmotic solutes on human mesothelial cells in vitro.

Authors:  A Breborowicz; H Rodela; D G Oreopoulos
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

5.  Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.

Authors:  W F Keane; C M Comty; H A Verbrugh; P K Peterson
Journal:  Kidney Int       Date:  1984-03       Impact factor: 10.612

6.  Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set.

Authors:  J L Holley; J Bernardini; B Piraino
Journal:  Am J Kidney Dis       Date:  1994-04       Impact factor: 8.860

7.  Fibronectin during CAPD-related peritonitis: no indications for intraperitoneal production.

Authors:  D Zemel; G C Koomen; D G Struijk; R T Krediet
Journal:  Blood Purif       Date:  1993       Impact factor: 2.614

8.  Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.

Authors:  B A Warady; S F Campoy; S P Gross; A B Sedman; G M Lum
Journal:  J Pediatr       Date:  1984-11       Impact factor: 4.406

9.  Adherence of Staphylococcus aureus to cultures of human peritoneal mesothelial cells.

Authors:  G Glancey; J S Cameron; C Ogg; S Poston
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

10.  Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.

Authors:  A Fattom; R Schneerson; D C Watson; W W Karakawa; D Fitzgerald; I Pastan; X Li; J Shiloach; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.609

View more
  9 in total

1.  Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-perform screening strategy.

Authors:  N Schnitzler; R Meilicke; G Conrads; D Frank; G Haase
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 2.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

Review 3.  Management of peritonitis in children receiving chronic peritoneal dialysis.

Authors:  Franz Schaefer
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  Drainage vs no drainage in secondary peritonitis with sepsis following complicated appendicitis in adults in the modern era of antibiotics.

Authors:  Sheraz Ahmed Rather; Shams Ul Bari; Ajaz A Malik; Asima Khan
Journal:  World J Gastrointest Surg       Date:  2013-11-27

5.  The utility of peritoneal drains in children with uncomplicated perforated appendicitis.

Authors:  B Tander; O Pektas; M Bulut
Journal:  Pediatr Surg Int       Date:  2003-07-19       Impact factor: 1.827

6.  Bacteria on catheters in patients undergoing peritoneal dialysis.

Authors:  Maria Pihl; Julia R Davies; Ann-Cathrine Johansson; Gunnel Svensäter
Journal:  Perit Dial Int       Date:  2012-08-01       Impact factor: 1.756

Review 7.  Dialysis-associated peritonitis in children.

Authors:  Vimal Chadha; Franz S Schaefer; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2009-02-04       Impact factor: 3.714

8.  WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.

Authors:  Ulrich Matt; Omar Sharif; Rui Martins; Tanja Furtner; Lorene Langeberg; Riem Gawish; Immanuel Elbau; Ana Zivkovic; Karin Lakovits; Olga Oskolkova; Bianca Doninger; Andreas Vychytil; Thomas Perkmann; Gernot Schabbauer; Christoph J Binder; Valery N Bochkov; John D Scott; Sylvia Knapp
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

9.  Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients.

Authors:  Evelina Ferrantelli; Karima Farhat; Agnes L Hipgrave Ederveen; Karli R Reiding; Robert H J Beelen; Frans J van Ittersum; Manfred Wuhrer; Viktoria Dotz
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.